Multidisciplinary Collaboration and Diagnostic Frameworks in Wilson Disease

In this episode, 'Multidisciplinary Collaboration and Diagnostic Frameworks in Wilson Disease,' the panelists explore the complex coordination required to manage this multi-organ condition. Dr. Rima Fawaz describes the multidisciplinary model used at the Yale Wilson Disease Registry, which integrates specialists from neurology, psychiatry, nutrition, and radiology to provide comprehensive care. This collaborative framework is essential because Wilson disease often presents as a "clinician's diagnosis," where no single test is universally definitive.

The experts delve into the utility of the Leipzig score, a weighted diagnostic tool that aggregates findings from ceruloplasmin levels, 24-hour urine copper collections, and clinical markers. A significant portion of the discussion focuses on the "new era" of genetic testing. Dr. Fawaz notes that next-generation sequencing is increasingly used for patients with unexplained liver enzyme elevations and for targeted sibling screening. In pediatric populations under age five, genetic testing is often the primary way to reach the required Leipzig score threshold, as other markers like urine copper may not yet be significantly elevated.

The panel also reviews the role of ophthalmologic findings, specifically Kayser-Fleischer (KF) rings. While historically viewed as a "window into the brain" and highly correlated with neurological symptoms, these copper deposits are found in only about 20% of pediatric registry patients and are nearly absent in children under 10. The experts emphasize that while KF rings are a classic sign that typically resolves with treatment, their absence does not rule out the disease. The episode concludes by reinforcing that clinicians must recognize patterns across laboratory, genetic, and physical findings to ensure an accurate diagnosis.

The next episode in this series, 'Addressing Diagnostic Challenges in Wilson Disease,' features the panelists advancing their conversation on Wilson disease and focusing on the common factors that contribute to misdiagnosis and delayed clinical recognition. Dr. Peter Hedera and Dr. Rima Fawaz outline the critical necessity of screening siblings of a diagnosed proband and discuss the evolving role of biochemical and genetic testing in identifying asymptomatic cases.